Yes, and the ceiling is set by a transporter rather than by the jar. Ascorbate enters cells through sodium-dependent carriers whose transport is saturable. Reported Michaelis constants are approximately 20 µM for SVCT2 and 65–237 µmol/L for SVCT1, with maximal rates near 1 and 15 pmol/min per cell respectively. Beyond those concentrations at the cell surface, uptake no longer rises in proportion.
Published 21 October 2026. Last reviewed 21 October 2026.
The terms, defined so they stand alone
Ascorbate. The anion of ascorbic acid, and the form in which vitamin C predominates at physiological pH. Because it carries a charge, it does not cross lipid membranes freely; it requires a protein carrier.
SVCT1 and SVCT2. Sodium-dependent vitamin C transporters, two membrane proteins that move ascorbate into a cell while coupling its entry to an inward flow of sodium. SVCT1 is the high-capacity, low-affinity carrier; SVCT2 the low-capacity, high-affinity one.
Michaelis constant (Km). The substrate concentration at which a carrier operates at half its maximal rate. It is an index of affinity: a low Km means the carrier is already working near its ceiling at low concentrations, so raising the concentration further buys little.
Maximal rate (Vmax). The transport rate a carrier reaches when it is fully occupied. It is a property of the protein and its abundance, not of the surrounding concentration, which is precisely why concentration cannot raise it.
Saturable transport. Movement mediated by a finite number of carrier proteins. Once they are occupied, additional substrate waits rather than entering. Passive diffusion has no such ceiling; carrier-mediated uptake does.
The numbers, and what kind of numbers they are
Lykkesfeldt and Tveden-Nyborg, reviewing the pharmacokinetics of vitamin C in Nutrients in 2019, characterise the two carriers as a "high capacity/low affinity SVCT1 (Vmax of about 15 pmol/min/cell and Km of about 65–252 µM" and a "low capacity/high affinity transporter of vitC (Vmax of about 1 pmol/min/cell and Km of about 8–69 µM". They attribute the non-linear, dose-dependent kinetics of the vitamin to "the dominant role of the saturable active transport mechanisms in the absorption, distribution, and excretion" of ascorbate.
Pullar, Carr and Vissers, writing on the roles of vitamin C in skin health, report a Km of 65–237 µmol/L for SVCT1 and of approximately 20 µM for SVCT2, and note a feature specific to this organ: "cells in the epidermis express both types of vitamin C transporter, SVCT1 and SVCT2", which "contrasts with most other tissues, which express SVCT2 only". Linowiecka and colleagues concur that SVCT1 is largely confined to epithelial tissues — the skin among them — while SVCT2 is "expressed in almost every cell in the human body".
Two consequences of the affinity figures are worth separating. The first is that the carriers are dimensioned for micromolar conditions. The second is that the cell nonetheless accumulates far more than it is bathed in: intracellular skin concentrations are, per the same review, "likely to be in the millimolar range", with "differences of 2–5-fold between the two layers being consistently reported" and the epidermis the richer of the two. A saturable carrier concentrating its substrate several orders of magnitude against a gradient is the expected behaviour of active transport, and it is why the ceiling exists.
| Carrier | Kinetic character | Km (reported range) | Vmax | Expression | Source |
|---|---|---|---|---|---|
| SVCT1 | High capacity, low affinity | 65–252 µM; 65–237 µmol/L | ~15 pmol/min per cell | Mainly epithelial tissues, including skin; epidermal cells express it, unusually | Lykkesfeldt & Tveden-Nyborg, 2019; Pullar et al., 2017; Linowiecka et al., 2020 |
| SVCT2 | Low capacity, high affinity | 8–69 µM; ~20 µM | ~1 pmol/min per cell | Almost every cell type | Lykkesfeldt & Tveden-Nyborg, 2019; Pullar et al., 2017; Linowiecka et al., 2020 |
The systemic analogue, stated as what it is
The clearest demonstration of a transport ceiling comes from oral dosing rather than topical application. With increasing intake, "the plasma steady state concentration reaches a maximal level of about 70–80 µM", and Pullar and colleagues observe that skin levels "do not increase further once plasma saturation is reached". This is strong evidence that the tissue has a ceiling — but it is evidence drawn from the plasma route. It does not, by itself, describe what happens at a keratinocyte membrane after a serum is applied to the surface, and it should not be presented as though it did.
Why the label percentage is a different variable
A formulated concentration is not a concentration at a transporter. Between the two lies the stratum corneum, and the fraction that crosses it is governed by the vehicle. A 2022 systematic review of permeation enhancers for topical vitamin C in Cosmetics quantifies that dependence: across the studies reviewed, enhancement ratios ranged from 0.198 to 106.57, with the highest values 106.57 in mouse skin and 69.24 in reconstructed human epidermis. Amino-acid enhancers produced "a 13 to 69-fold improvement in the topical delivery of l-ascorbic acid 2-glucoside" in reconstructed human epidermis, and polyols gave more modest ratios of 2.43–2.74 in porcine skin.
The same review records two figures in circulation in the sector — that content "greater than 8%" is required for biological significance, and that marketed products contain between 10 and 20 percent — and notes, pointedly, that in one of the reviewed studies the glucoside "from the control formulation is nearly undetectable in both buffers in the medium and skin". An ingredient present at a nominal percentage and undetectable in the tissue is the clearest available illustration of the distinction.
A variable with a span of two orders of magnitude dominates one that is capped. The formulation controls delivery; the carrier caps uptake. Which of the two a higher percentage on the label addresses is therefore not obvious, and in the absence of penetration data for the specific formulation it is not determinable at all.
The chemistry upstream of this constraint is treated separately in our articles on the pH requirement of L-ascorbic acid, on the stability of lipid-soluble esters, and on why a stable ester does not make a stable serum. Our open-access technical report on the pH constraint and on the oxidative stability of tetrahexyldecyl ascorbate is deposited under DOI 10.5281/zenodo.22491021.
What follows, and what does not
Ascorbate entry into a skin cell is carrier-mediated and saturable, and the affinity constants place the operating range of those carriers in the tens to low hundreds of micromolar. That is a well-supported mechanism and a real ceiling. It does not follow that any particular topical concentration is above or below it, because the concentration reaching the carrier is not the concentration in the container, and it is rarely reported.
Three limits apply. The kinetic constants come from transport studies in cell systems, not from measurements taken at a basal keratinocyte membrane after a topical dose. The epidermal expression of both carriers is a qualitative finding, not a quantified one, so the relative contribution of each in skin is unresolved. And the saturation evidence most often cited concerns plasma, with the topical route inferred rather than measured.
The honest formulation is that for vitamin C the binding constraint is almost certainly delivery rather than concentration, and that a claim about either requires measurement of the specific formulation rather than an argument from its percentage.
Scope
This article describes findings published in the peer-reviewed literature and the conditions under which they were obtained. It does not constitute a claim about any product, nor a statement of the performance of any formulation. Cosmetic products are not intended to diagnose, treat, cure or prevent disease.
References
- TTS Clinical Scientific Team (2026). Topical vitamin C: the pH constraint on L-ascorbic acid and the oxidative stability of tetrahexyldecyl ascorbate, v1.0. Zenodo. DOI 10.5281/zenodo.22491021 (concept DOI, all versions: 10.5281/zenodo.22491019). CC BY 4.0.
- Lykkesfeldt, J. & Tveden-Nyborg, P. (2019). The pharmacokinetics of vitamin C. Nutrients, 11(10), 2412. DOI 10.3390/nu11102412. PMID 31601028.
- Pullar, J. M., Carr, A. C. & Vissers, M. C. M. (2017). The roles of vitamin C in skin health. Nutrients, 9(8), 866. DOI 10.3390/nu9080866.
- Linowiecka, K., Foksinski, M. & Brożyna, A. A. (2020). Vitamin C transporters and their implications in carcinogenesis. Nutrients, 12(12), 3869. DOI 10.3390/nu12123869.
- Liston, L. S., Rivas, P. L., Sakdiset, P., See, G. L. & Arce, F. Jr. (2022). Chemical permeation enhancers for topically-applied vitamin C and its derivatives: a systematic review. Cosmetics, 9(4), 85. DOI 10.3390/cosmetics9040085.